Escondido, CANCT06581328Now EnrollingIRB Ready

Inflammatory Bowel Disease Clinical Trial in Escondido, CA

Access cutting-edge inflammatory bowel disease treatment through this clinical trial at a research site in Escondido. Study-provided care at no cost to qualified participants.

Sponsored by Takeda

Quick Self-Assessment

See if you qualify for this Escondido location

Preparing your pre-screening questions...

Expert Care in Escondido

Access inflammatory bowel disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related inflammatory bowel disease treatment provided free

Apply for This Escondido Location

Check if you qualify for this inflammatory bowel disease clinical trial in Escondido, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Escondido

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Escondido site if eligible
  4. 4Begin participation

About This Inflammatory Bowel Disease Study in Escondido

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 months (14 weeks) of treatment with Vedolizumab (this is called remission). Participants will be treated with Vedolizumab for approximately 1 year (50 weeks). During the first 1.5 months (6 weeks), partici

Sponsor: Takeda

Who Can Participate

Inclusion Criteria

To be eligible to participate in this study, participants must meet all the following criteria: 1. In the investigator's opinion, the participant can understand and comply with protocol requirements. 2. The participant signs and dates an electronic informed consent form (ICF) and any required privacy authorization prior to any study procedures. 3. The participant is 18 to 80 years of age at the time of signing the ICF. 4. The participant's immunization is up to date per vedolizumab US prescribing information (USPI). 5. If participant is a woman of childbearing potential (WOCBP): 1. Agrees to use at least 1 form of highly effective contraception from signing the ICF until at least 18 weeks after the last dose of vedolizumab. 2. Agrees to avoid donating ova from signing the ICF throughout the duration of the study and for 18 weeks after the last dose of vedolizumab. 3. Has a negative urine pregnancy test within 3 days before first dose of vedolizumab. 4.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Escondido?

Yes, this clinical trial (NCT06581328) has an active research site in Escondido, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Inflammatory Bowel Disease Treatment Options in Escondido, CA

If you're searching for inflammatory bowel disease treatment options in Escondido, CA, this clinical trial (NCT06581328) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Escondido research site is actively enrolling participants for this clinical trial. You'll receive care from experienced inflammatory bowel disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all inflammatory bowel disease clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Escondido, CA

See all multiple myeloma clinical trials recruiting in Escondido — not just this study.

Browse Multiple Myeloma Trials in Escondido

Ready to Join in Escondido?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Escondido, CA